Early phase insulin infusion and muscarinic blockade in obese and lean subjects

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 277, Issue 1 46-1, 1999, Pages

  Teff, Karen L ^a,b   Townsend, Raymond R ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b MONELL CHEMICAL SENSES CENTER   (United States)

Author keywords

Cephalic phase; Glucagon; Glucose; Insulin; Obesity; Parasympathetic nervous system; Vagus

Indexed keywords

ADULT; ARTICLE; CHOLINERGIC SYSTEM; FOOD INTAKE; GLUCOSE METABOLISM; HUMAN; INSULIN METABOLISM; INSULIN RELEASE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; STOMACH EMPTYING;

EID: 0032768287     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.277.1.r198     Document Type: Article

References (58)

1. Adkins, B. A., S. R. Myers, G. K. Hendrick, R. W. Stevenson, P. E. Williams, and A. D. Cherrington. Importance of the route of intravenous glucose delivery on hepatic glucose balance in the conscious dog. J. Clin. Invest. 79: 557-565, 1987.
2. Adkins-Marshall, B., M. J. Pagliassotti, J. R. Asher, C. C. Connolly, D. W. Neal, P. E. Williams, S. R. Myers, G. K. Hendrick, R. B. Adkins, Jr., and A. D. Cherrington. Role of hepatic nerves in response of liver to intraportal glucose delivery in dogs. Am. J. Physiol. 262 (Endocrinol. Metab. 25): E679-E686, 1992.
3. Balks, H., J. J. Holst, A. von zur Muhlen, and G. Brabant. Rapid oscillations in plasma glucagon-like peptide-1 (GLP) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors. J. Clin. Endocrinol. Metab. 82: 786-790, 1997.
4. Bergman, R. N., and R. E. Miller. Direct enhancement of insulin secretion by vagal stimulation of the isolated pancreas. Am. J. Physiol. 225: 481-486, 1973.
5. Bevan, J. S., J. Ara, M. D. Page, M. F. Scanlo, and J. R. Peters. Cholinergic blockage with pirenzipine induces dose-related reduction in glucose and insulin responses to a mixed meal in normal subjects and non-insulin dependent diabetics. Clin. Endocrinol. Metab. 35: 85-91, 1991.
6. Bloom, S. R., N. J. A. Vaughan, and R. C. G. Russel. Vagal control of glucagon release in man. Lancet 2: 546-549, 1974.
7. Boyle, J. G., S. B. Liggett, S. D. Shah, and P. E. Cryer. Direct muscarinic cholinergic inhibition of hepatic glucose production in humans. J. Clin. Invest. 82: 445-449, 1988.
8. Bruce, D. G., D. J. Chisholm, L. H. Storlien, and E. W. Kraegen. Physiological importance of deficiency in early prandial insulin secretion in non-insulin dependent diabetics. Diabetes 37: 736-744, 1988.
9. Calles-Escandon, J., and D. C. Robbins. Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose. Diabetes 36: 1167-1172, 1987.
10. Campfield, L. A., and F. J. Smith. Neural control of insulin secretion: interaction of norepinephrine and acetylcholine. Am. J. Physiol. 244 (Regulatory Integrative Comp. Physiol. 13): R629-R634, 1983.
11. Cherrington, A. D., B. A. Marshall, M. C. Moore, M. J. Pagliosotti, and M. Shiota. A role for the autonomic nervous system in regulation of glucose uptake by the liver. In: Liver Innervation, edited by T. Shimazu. London: Libbey, 1996, p. 123-126.
12. DeFronzo, R. A., E. Ferrannini, R. Hendler, J. Wahren, and P. Felig. Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. Proc. Natl. Acad. Sci. USA 75: 5173-5177, 1978.
13. Del Rio, G., M. Procopio, M. Bondi, P. Marrama, R. Menozzi, S. E. Oleandri, S. Grottoli, M. Maccario, A. Velardo, and E. Ghigo. Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects. Int. J. Obes. 21: 1111-1114, 1997.
14. Fukudo, S., Virnelli, S., C. M. Kuhn, C. Cochrane, M. N. Feinglos, and R. S. Surwit. Muscarinic stimulation and antagonism and glucoregulation in nondiabetic and obese hyperglycemic mice. Diabetes 38: 1433-1438, 1989.
15. Henderson, J. R., D. B. Jeffreys, R. H. Jones, and D. Stanley. The effect of atropine on the insulin release caused by oral and intravenous glucose in human subjects. Acta Endocrinol. 83: 772-780, 1976.
16. Hevener, A. L., R. Bergman, and C. M. Donovan. Novel glucosensor for hypoglycemic detection localized to the portal vein. Diabetes 46: 1521-1525, 1997.
17. Jeanrenaud, B. An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause. Diabetologia 28: 502-513, 1985.
18. Johnson, W. G., and H. E. Wildman. Influence of external and covert food stimuli on insulin secretion in obese and normal persons. Behav. Neurosci. 97: 1025-1028, 1983.
19. Kaneto, A., K. Kosaka, and K. Nakao. Effects of stimulation of the vagus nerve on insulin secretion. Endocrinology 80: 530-536, 1967.
20. Katschinski, M., C. Steinicke, M. Reinshagen, G. Dahmen, C. Beglinger, R. Arnold, and G. Adler. Gastrointestinal motor and secretory responses to cholinergic stimulation in humans. Differential modulation by muscarinic and cholecystokinin receptor blockade. Eur. J. Clin. Invest. 25: 113-122, 1995.
21. Kraegan, E. W., D. J. Chisholm, and M. E. McNamara. Timing of insulin delivery with meals. Horm. Metab. Res. 13: 365-367, 1981.
22. Lee, H. C., D. L. Curry, and J. S. Stern. Tonic sympathetic nervous system inhibition of insulin secretion is diminished in obese Zucker rats. Obes. Res. 1: 371-376, 1993.
23. Maccario, M., S. Grottoli, M. Procopio, S. E. Oleandri, G. M. Boffano, P. Savio, F. Camanni, and E. Ghigo. Effects of cholinergic blockade by pirenzipine on insulin and glucose response to oral and intravenous glucose and to arginine load in obesity. J. Endocrinol. Invest. 20: 8-12, 1997.
24. Meglasson, M. D., H. Najafi, and F. M. Matschinsky. Acetylcholine stimulates glucose metabolism in pancreatic islets. Life Sci. 39: 1745-1750, 1986.
25. Mitrakou, A., M. Mokan, G. B. Bolli, T. Veneman, T. Jenssen, P. Cryer, and J. Gerich. Evidence against the hypothesis that hyperinsulinemia increases sympathetic nervous system activity in man. Metabolism 41: 198-200, 1992.
26. Mittelman, S. D., Y. Y. Fu, K. Rebrin, G. Steil, and R. N. Bergman. Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. J. Clin. Invest. 100: 3121-3130, 1997.
27. Morishita, T., and P. H. Guth. Vagal nerve stimulation causes noncholinergic dilatation of gastric arterioles. Am. J. Physiol. 250 (Gastrointest. Liver Physiol. 13): G660-G664, 1986.
28. Nacht, C. A., L. Christin, E. Temler, R. Chiolero, E. Jequier, and K. J. Acheson. Thermic effect of food: possible implication of the parasympathetic nervous system. Am. J. Physiol. 253 (Endocrinol. Metab. 16): E481-E488, 1987.
29. Nauck, M. A., U. Niedereichholz, R. Etler, J. J. Hoist, C. Orskov, R. Ritzel, and W. H. Schmiegel. Glucagon-like peptide 1 inhibition of gastric emptying outweights its insulinotropic effects in healthy humans. Am. J. Physiol. 273 (Endocrinol. Metab. 36): E981-E988, 1997.
30. Pagliassotti, M. J., L. C. Holste, M. C. Moore, D. W. Neal, and A. D. Cherrington. Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog. J. Clin. Invest. 97: 81-91, 1996.
31. Powley, T. L. The ventromedial hypothalamic syndrome, satiety and a cephalic phase hypothesis. Psychol. Rev. 84: 89-126, 1977.
32. Premawardhana, L. D., I. S. Ismail, D. Riad-Faymy, J. P. Miell, J. R. Peters, and M. F. Scanlon. Acute cholinergic blockade with low dose pirenzipine reduces the insulin and glucose responses to a mixed meal in obese women with the polycystic ovary syndrome. Clin. Endocrinol. Metab. 40: 617-621, 1994.
33. Proietto, J., F. Rohner-Jeanrenaud, E. Ionescu, and B. Jeanrenaud. Role of the oropharynx in the regulation of glycemia. Diabetes 36: 791-795, 1987.
34. Reaven, G. M., H. Lithell, and L. Landsberg. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N. Engl. J. Med. 334: 374-381, 1996.
35. Rebrin, K., G. M. Steil, L. Getty, and R. N. Bergman. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44: 1038-1045, 1995.
36. Rodin, J. Has the distinction between internal versus external control of feeding outlived its usefulness? In: Recent Advances in Obesity, edited by G. A. Bray. London: Neuman, 1978, p. 75-85.
37. Rogers, R., D. McTigue, and G. Hermann. Vagal control of digestion: modulation by central neural and peripheral endocrine factors. Neurosci. Biobehav. Rev. 20: 57-66, 1996.
38. Rohner-Jeanrenaud, F., A. C. Hochstrasser, and B. Jeanrenaud. Hyperinsulinemia of preobese and obese fa/fa rats is partly vagus nerve mediated. Am. J. Physiol. 244 (Endocrinol. Metab. 7): E317-E322, 1983.
39. Rohner-Jeanrenaud, F., and B. Jeanrenaud. Involvement of the cholinergic system in insulin and glucagon oversecretion of genetic preobesity. Endocrinology 116: 830-834, 1985.
40. Schmid, R., V. Schusdziarra, E. Schulte-Frohlinde, V. Maier, and M. Classen. Circulating amino acids and pancreatic endocrine function after ingestion of a protein-rich meal in obese subjects. J. Clin. Endocrinol. Metab. 68: 1106-1110, 1989.
41. Schneeberger, D., L. Tappy, E. Temler, and E. Jequier. Effects of muscarinic blockade on insulin secretion and on glucose-induced thermogenesis in lean and obese humans. Eur. J. Clin. Invest. 21: 608-615, 1991.
42. Schwartz, T. W., J. J. Holst, J. Fahrenkrug, S. Lindkaer Jensen, O. V. Nielsen, O. B. Schaffalitzky de Muckadell, and F. Stadil. Vagal, cholinergic regulation of pancreatic polypeptide secretion. J. Clin. Invest. 61: 781-789, 1978.
43. Shimazu, T. Glycogen synthetase activity in liver: regulation by the autonomic nerves. Science 156: 1256-1257, 1967.
44. Sjostrom, L., G. Garellick, M. Krotkiewski, and A. Luyckx. Peripheral insulin in response to the sight and smell of a food. Metabolism 29: 901-909, 1980.
45. Steffens, A. B. Influence of the oral cavity on insulin release in the rat. Am. J. Physiol. 230: 1411-1415, 1976.
46. Storlien, L. H. The role of the ventromedial hypothalamic area in periprandial glucoregulation. Life Sci. 36: 505-514, 1985.
47. Storlien, L. H., and D. G. Bruce. Mind over metabolism: the cephalic phase in relation to non-insulin-dependent diabetes and obesity. Biol. Psychol. 28: 3-23, 1989.
48. Stumpel, F., T. Kucera, A. Garemann, and K. Jungermann. Involvement of enterohepatic and hepatoenteral nerves in the regulation of intestinal glucose absorption and hepatic glucose absorption and hepatic glucose uptake in rats: studies with the isolated, jointly perfused intestine and liver. In: Liver Innervation, edited by T. Shimazu. London: Libbey, 1996, p. 157-165.
49. Tappy, L., O. Chiolero, J. P. Randin, P. Burckhardt, and J. P. Felber. Effects of cholinergic stimulation and antagonism on plasma insulin concentration in lean and obese human subjects. Horm. Metab. Res. 18: 821-826, 1986.
50. Teff, K. L., A. Alavi, J. Chen, M. Pourdehnad, and R. R. Townsend. Muscarinic blockade inhibits gastric emptying of mixed-nutrient meal: effects of weight and gender. Am. J. Physiol. 276 (Regulatory Integrative Comp. Physiol. 45): R707-R714, 1999.
51. Teff, K. L., and K. Engelman. Oral sensory stimulation improves glucose tolerance in humans: effects on insulin, C-peptide, and glucagon. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R1371-R1379, 1996.
52. Teff, K. L., B. L. Levin, and K. Engelman. Oral sensory stimulation in men: effects on insulin, C-peptide, and catecholamines. Am. J. Physiol. 265 (Regulatory Integrative Comp. Physiol. 34): R1223-R1230, 1993.
53. Teff, K. L., R. D. Mattes, and K. Engelman. Cephalic phase insulin release in normal weight males: verification and reliability. Am. J. Physiol. 261 (Endocrinol. Metab. 24): E430-E436, 1991.
54. Teff, K. L., R. D. Mattes, and K. Engelman. Cephalic-phase insulin in obese and normal-weight men: relation to postprandial insulin. Metabolism 42: 1600-1608, 1993.
55. Trimble, E. R., H. R. Berthoud, E. G. Siegel, B. Jeanrenaud, and A. E. Renold. Importance of cholinergic innervation of the pancreas for glucose tolerance in the rat. Am. J. Physiol. 241 (Endocrinol. Metab. 4): E337-E341, 1981.
56. Xie, H., and W. W. Lautt. Induction of insulin resistance by cholinergic blockade with atropine in the cat. J. Auton. Pharmacol. 15: 361-369, 1995.
57. Yano, S., A. Fujiwara, Y. Ozaki, and M. Harada. Gastric blood flow responses to autonomic nerve stimulation and related pharmacological studies in rats. J. Pharm. Pharmacol. 35: 641-646, 1983.
58. Zawalich, W. S., K. C. Zawalich, and H. Rasmussen. Cholinergic agonists prime the B-cell to glucose stimulation. Endocrinology 125: 2400-2406, 1989.